speb/financial-data huggingface dataset:
Financial ratios for DBX — annual report dated 2025-12-31
Total revenue: 2521000000
Gross profit: 2020200000
Operating income: 687800000
Net income: 508400000
Capital expenditures: 17100000
Operating cash flow: 951800000
Depreciation & amortization: 157400000
Net tangible assets: -2285800000
Owner earnings: 648700000
Return on net tangible assets (%): -28.379560766471258
Capex to operating income (%): 2.4861878453038675
Buffett classification: The Great
Stock price: 27.8
P/E ratio: 8.641697914240757
Shares outstanding: 158037382
Book value: -1797200000
Market cap (USD): 4393439219.6
Debt to equity: -1.995882483863788
Current ratio: 0.6287298653287563
Quick ratio: 0.6287298653287563
Effective tax rate (%): 17.681347150259068
Interest coverage ratio: 8.750636132315522
COGS to revenue (%): 19.86513288377628
R&D to revenue (%): 29.03609678698929
SG&A to revenue (%): 23.81594605315351
Free cash flow (dilution-adjusted): 629600000
Buyback yield (%): 39.01044066693704
Retained earnings: -3815100000
Receivables turnover: 31.871049304677623
Capitalized R&D asset: 1654028000
ROCI (R&D-adjusted, %): 21.44241432373747
Rosenberg metric: -0.09061099573723905
FCF margin (%): 24.974216580721937
Revenue growth (%): -1.0674201397064593
Rule of 40 score: 23.906796441015477
Financial ratios for DBX — quarterly report dated 2025-12-31
Total revenue: 636200000
Gross profit: 504100000
Operating income: 158300000
Net income: 108700000
Capital expenditures: 2900000
Operating cash flow: 235400000
Depreciation & amortization: 40700000
Net tangible assets: -2285800000
Owner earnings: 146500000
Return on net tangible assets (%): -6.409134657450346
Capex to operating income (%): 1.831964624131396
Buffett classification: The Great
Stock price: 27.8
P/E ratio: 8.641697914240757
Shares outstanding: 158037382
Book value: -1797200000
Market cap (USD): 4393439219.6
Debt to equity: -1.995882483863788
Current ratio: 0.6287298653287563
Quick ratio: 0.6287298653287563
Effective tax rate (%): 24.039133473095735
COGS to revenue (%): 20.763910719899403
R&D to revenue (%): 29.377554228230117
SG&A to revenue (%): 24.97642250864508
Free cash flow (dilution-adjusted): 147500000
Buyback yield (%): 9.44590283959325
Retained earnings: -3815100000
Receivables turnover: 8.042983565107459
Capitalized R&D asset: 369893000
ROCI (R&D-adjusted, %): 12.159806088934602
Rosenberg metric: -0.010970927043335162
FCF margin (%): 23.184533165671173
Revenue growth (%): 0.2837326607818411
Rule of 40 score: 23.468265826453013
Financial ratios for EAD — annual report dated 2022-04-30
Total revenue: -28716808
Net income: -29530990
Capital expenditures: 0
Operating cash flow: 43913262
Depreciation & amortization: 1218795
Net tangible assets: 479456952
Owner earnings: -28312195
Return on net tangible assets (%): -5.90505464190245
Buffett classification: The Gruesome
Stock price: 5.08
Shares outstanding: 59092336
Book value: 479456952
P/B ratio: 0.6261022300913472
Market cap (USD): 300189066.88
Debt to equity: 0.40462443852519214
Free cash flow (dilution-adjusted): 43913262
Buyback yield (%): 0.8735881114045722
Retained earnings: -90805964
Receivables turnover: -1.9512208512481253
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EAD — annual report dated 2023-04-30
Total revenue: -9391084
Net income: -10135314
Capital expenditures: 0
Operating cash flow: 49143644
Depreciation & amortization: 0
Net tangible assets: 425866901
Owner earnings: -10135314
Return on net tangible assets (%): -2.3799252715345447
Buffett classification: The Gruesome
Stock price: 4.75
Shares outstanding: 59092336
Book value: 425866901
P/B ratio: 0.6590993461593297
Market cap (USD): 280688596
Debt to equity: 0.4438006324422005
Free cash flow (dilution-adjusted): 49143644
Buyback yield (%): 1.367566069552751
Retained earnings: -132130171
Receivables turnover: -0.5562750624374818
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EAD — annual report dated 2024-04-30
Total revenue: 38932115
Net income: 38337679
Capital expenditures: 0
Operating cash flow: 38807436
Depreciation & amortization: 0
Net tangible assets: 425311174
Owner earnings: 38337679
Return on net tangible assets (%): 9.014030513103801
Buffett classification: The Gruesome
Stock price: 5.27
P/E ratio: 8.122990719391229
Shares outstanding: 59092336
Book value: 425311174
P/B ratio: 0.7322088620225153
Market cap (USD): 311416610.71999997
Debt to equity: 0.4443805184389536
COGS to revenue (%): 0
SG&A to revenue (%): 1.4325319854829361
Free cash flow (dilution-adjusted): 38807436
Buyback yield (%): 0
Retained earnings: -125849233
Receivables turnover: 3.425293162068008
Capitalized R&D asset: 0
FCF margin (%): 99.6797528210322
Rule of 40 score: 99.6797528210322
Financial ratios for EAD — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 435604435
Buffett classification: The Gruesome
Stock price: 5.84
Shares outstanding: 59092336
Book value: 435604435
P/B ratio: 0.7922307821314996
Market cap (USD): 345099242.24
Debt to equity: 0.4338798800338201
Buyback yield (%): 0
Retained earnings: -115555972
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EAD — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 423413725
Buffett classification: The Gruesome
Stock price: 6.04
Shares outstanding: 59092336
Book value: 423413725
P/B ratio: 0.8429526214342722
Market cap (USD): 356917709.44
Debt to equity: 0.446371926181656
Buyback yield (%): 0
Retained earnings: -123337617
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EAD — annual report dated 2025-04-30
Total revenue: 36232350
Net income: 35476681
Capital expenditures: 0
Operating cash flow: 37689802
Depreciation & amortization: 0
Net tangible assets: 423413725
Owner earnings: 35476681
Return on net tangible assets (%): 8.378727212964105
Buffett classification: The Gruesome
Stock price: 6.04
P/E ratio: 10.06062854188643
Shares outstanding: 59092336
Book value: 423413725
P/B ratio: 0.8429526214342722
Market cap (USD): 356917709.44
Debt to equity: 0.446371926181656
COGS to revenue (%): 0
SG&A to revenue (%): 2.0047498989163
Free cash flow (dilution-adjusted): 37689802
Buyback yield (%): 0
Retained earnings: -123337617
Receivables turnover: 1.786259140057051
Capitalized R&D asset: 0
FCF margin (%): 104.02251579044695
Revenue growth (%): -6.934544912342934
Rule of 40 score: 97.08797087810402
Financial ratios for EAD — quarterly report dated 2025-10-31
Capital expenditures: 0
Net tangible assets: 435961085
Buffett classification: The Gruesome
Stock price: 6.5
Shares outstanding: 59092336
Book value: 435961085
P/B ratio: 0.8810423618429154
Market cap (USD): 384100184
Debt to equity: 0.38764927837538526
Buyback yield (%): 0
Retained earnings: -110790257
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EG1.AX — annual report dated 2023-06-30
Operating income: -3419843.7086092713
Net income: -3401094.701986755
Capital expenditures: 85905.96026490066
Depreciation & amortization: 10074.172185430463
Net tangible assets: 13397325.82781457
Owner earnings: -3476926.490066225
Return on net tangible assets (%): -25.95239180380072
Buffett classification: The Gruesome
Stock price: 0.2185430463576159
Shares outstanding: 428649767
Book value: 13397325.827814568
P/B ratio: 6.992322729523666
Market cap (USD): 93678425.90066226
Debt to equity: 0
Current ratio: 11.416440595749268
Quick ratio: 11.416440595749268
Interest coverage ratio: -129099.09999999999
Free cash flow (dilution-adjusted): -2782009.271523179
Buyback yield (%): 0.03534707427361124
Retained earnings: -4182908.609271523
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.525830080917544
Rule of 40 score: 0
Financial ratios for EG1.AX — annual report dated 2024-06-30
Operating income: -3716789.3333333335
Net income: -3613734
Capital expenditures: 39994.666666666664
Depreciation & amortization: 16094
Net tangible assets: 11054740.666666666
Owner earnings: -3637634.6666666665
Return on net tangible assets (%): -32.90565356847509
Buffett classification: The Gruesome
Stock price: 0.04666666666666667
Shares outstanding: 428649767
Book value: 11054740.666666666
P/B ratio: 1.8095092771963714
Market cap (USD): 20003655.793333333
Debt to equity: 0
Current ratio: 18.39943050524983
Quick ratio: 18.39943050524983
Interest coverage ratio: -12757.858123569795
Free cash flow (dilution-adjusted): -2073429.3333333333
Buyback yield (%): 0
Retained earnings: -7824528.666666667
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -33.62061172779698
Rule of 40 score: 0
Financial ratios for ELSE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.28
Shares outstanding: 3532423
Market cap (USD): 22183616.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELSE — annual report dated 2022-12-31
Total revenue: 9029000
Gross profit: 4841000
Operating income: -37000
Net income: 100000
Capital expenditures: 65000
Operating cash flow: -147000
Depreciation & amortization: 145000
Net tangible assets: 13414000
Owner earnings: 180000
Return on net tangible assets (%): 1.3418816162218576
Buffett classification: The Gruesome
Stock price: 4.52
P/E ratio: 159.66551959999998
Shares outstanding: 3532423
Book value: 13414000
P/B ratio: 1.1902901416430594
Market cap (USD): 15966551.959999999
Debt to equity: 0.0004472938720739526
Current ratio: 20.33809523809524
Quick ratio: 17.56825396825397
Effective tax rate (%): -38.88888888888889
Interest coverage ratio: -37
COGS to revenue (%): 46.38387418318751
R&D to revenue (%): 9.259054158821575
SG&A to revenue (%): 44.76686233248422
Free cash flow (dilution-adjusted): -215000
Buyback yield (%): 0
Retained earnings: 10908000
Inventory turnover: 2.4
Receivables turnover: 7.703924914675768
Capitalized R&D asset: 836000
ROCI (R&D-adjusted, %): 3.6514619883040935
FCF margin (%): -2.381216081515118
Rule of 40 score: -2.381216081515118
Financial ratios for ELSE — annual report dated 2023-12-31
Total revenue: 8555000
Gross profit: 4245000
Operating income: -28000
Net income: 275000
Capital expenditures: 70000
Operating cash flow: 321000
Depreciation & amortization: 94000
Net tangible assets: 13755000
Owner earnings: 299000
Return on net tangible assets (%): 2.173754998182479
Buffett classification: The Gruesome
Stock price: 3.8
P/E ratio: 48.81166327272727
Shares outstanding: 3532423
Book value: 13755000
P/B ratio: 0.9758784005816067
Market cap (USD): 13423207.399999999
Debt to equity: 0
Current ratio: 19.042028985507248
Quick ratio: 16.504347826086956
Effective tax rate (%): 27.24867724867725
Interest coverage ratio: -28
COGS to revenue (%): 50.37989479836354
R&D to revenue (%): 11.373465809468147
SG&A to revenue (%): 38.573933372296906
Free cash flow (dilution-adjusted): 184000
Buyback yield (%): 0
Retained earnings: 11183000
Inventory turnover: 2.4614505996573386
Receivables turnover: 6.667965705378021
Capitalized R&D asset: 1533120
ROCI (R&D-adjusted, %): 2.2370311065062283
Rosenberg metric: -0.7129186602870813
FCF margin (%): 2.1507890122735245
Revenue growth (%): -5.249750802968213
Rule of 40 score: -3.098961790694689
Financial ratios for ELSE — quarterly report dated 2024-09-30
Capital expenditures: 4000
Buffett classification: The Gruesome
Stock price: 4
Shares outstanding: 3532423
Market cap (USD): 14129692
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELSE — annual report dated 2024-12-31
Total revenue: 9373000
Gross profit: 4582000
Operating income: -4000
Net income: 446000
Capital expenditures: 51000
Operating cash flow: 129000
Depreciation & amortization: 92000
Net tangible assets: 14333000
Owner earnings: 487000
Return on net tangible assets (%): 3.397753436126422
Buffett classification: The Gruesome
Stock price: 5.17
P/E ratio: 40.947593968609866
Shares outstanding: 3532423
Book value: 14333000
P/B ratio: 1.2741663929393705
Market cap (USD): 18262626.91
Debt to equity: 0
Current ratio: 24.409420289855074
Quick ratio: 20.85144927536232
Effective tax rate (%): -2.293577981651376
COGS to revenue (%): 51.11490451296277
R&D to revenue (%): 10.80763896297877
SG&A to revenue (%): 38.12013229488957
Free cash flow (dilution-adjusted): -54000
Buyback yield (%): 0
Retained earnings: 11629000
Inventory turnover: 2.4394093686354377
Receivables turnover: 7.160427807486631
Capitalized R&D asset: 1940790
ROCI (R&D-adjusted, %): 0.41989808970948606
Rosenberg metric: 0.34635149023638234
FCF margin (%): -0.5761229062199936
Revenue growth (%): 9.561659848042082
Rule of 40 score: 8.985536941822089
Financial ratios for ELSE — quarterly report dated 2024-12-31
Capital expenditures: 21000
Buffett classification: The Gruesome
Stock price: 5.17
Shares outstanding: 3532423
Market cap (USD): 18262626.91
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELSE — quarterly report dated 2025-03-31
Total revenue: 2239000
Gross profit: 1084000
Operating income: -169000
Net income: -64000
Capital expenditures: 0
Operating cash flow: -30000
Depreciation & amortization: 23000
Net tangible assets: 14300000
Owner earnings: -41000
Return on net tangible assets (%): -0.2867132867132867
Buffett classification: The Gruesome
Stock price: 4.39
Shares outstanding: 3532423
Book value: 14300000
P/B ratio: 1.0844291587412587
Market cap (USD): 15507336.969999999
Debt to equity: 0
Current ratio: 17.479643765903308
Quick ratio: 14.922391857506362
COGS to revenue (%): 51.585529254131316
R&D to revenue (%): 10.987047789191603
SG&A to revenue (%): 44.97543546225994
Free cash flow (dilution-adjusted): -61000
Buyback yield (%): 0
Retained earnings: 11565000
Inventory turnover: 0.5746268656716418
Receivables turnover: 1.471090670170828
Capitalized R&D asset: 246000
ROCI (R&D-adjusted, %): -0.03437371098583803
FCF margin (%): -2.7244305493523897
Rule of 40 score: -2.7244305493523897
Financial ratios for ELSE — quarterly report dated 2025-06-30
Total revenue: 2400000
Gross profit: 1228000
Operating income: -2000
Net income: 59000
Capital expenditures: 13000
Operating cash flow: 277000
Depreciation & amortization: 22000
Net tangible assets: 14391000
Owner earnings: 68000
Return on net tangible assets (%): 0.47251754568827736
Buffett classification: The Gruesome
Stock price: 4.23
P/E ratio: 63.31419190677967
Shares outstanding: 3532423
Book value: 14391000
P/B ratio: 1.0382981926203878
Market cap (USD): 14942149.290000001
Debt to equity: 0
Current ratio: 17.921976592977895
Quick ratio: 15.308192457737322
Effective tax rate (%): 26.25
Interest coverage ratio: -0.3333333333333333
COGS to revenue (%): 48.833333333333336
R&D to revenue (%): 8.916666666666668
SG&A to revenue (%): 42.333333333333336
Free cash flow (dilution-adjusted): 232000
Buyback yield (%): 0
Retained earnings: 11624000
Inventory turnover: 0.5830845771144278
Receivables turnover: 1.7725258493353029
Capitalized R&D asset: 378820
ROCI (R&D-adjusted, %): 0.3972063753428725
Rosenberg metric: 0.5853658536585366
FCF margin (%): 9.666666666666666
Revenue growth (%): 7.190710138454667
Rule of 40 score: 16.857376805121334
Financial ratios for ELSE — quarterly report dated 2025-09-30
Total revenue: 2748000
Gross profit: 1458000
Operating income: 181000
Net income: 208000
Capital expenditures: 6000
Operating cash flow: 395000
Depreciation & amortization: 23000
Net tangible assets: 14688000
Owner earnings: 225000
Return on net tangible assets (%): 1.531862745098039
Capex to operating income (%): 3.314917127071823
Buffett classification: The Great
Stock price: 4.78
P/E ratio: 83.17725093596059
Shares outstanding: 3532423
Book value: 14688000
P/B ratio: 1.1495766571350765
Market cap (USD): 16884981.94
Debt to equity: 0
Current ratio: 13.765490943755958
Quick ratio: 11.792183031458531
Effective tax rate (%): 23.52941176470588
COGS to revenue (%): 46.943231441048034
R&D to revenue (%): 8.624454148471617
SG&A to revenue (%): 37.84570596797671
Free cash flow (dilution-adjusted): 300000
Buyback yield (%): 0
Retained earnings: 11832000
Inventory turnover: 0.6231884057971014
Receivables turnover: 1.8356713426853708
Capitalized R&D asset: 461560
ROCI (R&D-adjusted, %): 1.2255581460231626
Rosenberg metric: 1.074766355140187
FCF margin (%): 10.91703056768559
Revenue growth (%): 14.499999999999998
Rule of 40 score: 25.417030567685586
Financial ratios for ELSE — annual report dated 2025-12-31
Total revenue: 10142000
Gross profit: 5157000
Operating income: 2000
Net income: 306000
Capital expenditures: 65000
Operating cash flow: 662000
Depreciation & amortization: 89000
Net tangible assets: 14817000
Owner earnings: 330000
Return on net tangible assets (%): 2.2271714922048997
Capex to operating income (%): 3250
Buffett classification: The Gruesome
Stock price: 4.16
P/E ratio: 48.022482614379086
Shares outstanding: 3532423
Book value: 14817000
P/B ratio: 0.991758094081123
Market cap (USD): 14694879.68
Debt to equity: 0
Current ratio: 16.218079096045198
Quick ratio: 13.926553672316384
Effective tax rate (%): 11.815561959654179
Interest coverage ratio: 0.3333333333333333
COGS to revenue (%): 49.15204101755078
R&D to revenue (%): 9.77124827450207
SG&A to revenue (%): 41.05699073161112
Free cash flow (dilution-adjusted): 419000
Buyback yield (%): 0
Retained earnings: 11935000
Inventory turnover: 2.4580867850098618
Receivables turnover: 6.8712737127371275
Capitalized R&D asset: 1990800
ROCI (R&D-adjusted, %): 0.003966412419630337
Rosenberg metric: 0.5676209279368213
FCF margin (%): 4.131335042397949
Revenue growth (%): 8.20441694228102
Rule of 40 score: 12.335751984678968
Financial ratios for ELSE — quarterly report dated 2025-12-31
Total revenue: 2755000
Gross profit: 1387000
Operating income: -8000
Net income: 103000
Capital expenditures: 46000
Operating cash flow: 20000
Depreciation & amortization: 21000
Net tangible assets: 14817000
Owner earnings: 78000
Return on net tangible assets (%): 0.5264223527029763
Buffett classification: The Gruesome
Stock price: 4.16
P/E ratio: 48.022482614379086
Shares outstanding: 3532423
Book value: 14817000
P/B ratio: 0.991758094081123
Market cap (USD): 14694879.68
Debt to equity: 0
Current ratio: 16.218079096045198
Quick ratio: 13.926553672316384
Effective tax rate (%): -35.526315789473685
COGS to revenue (%): 49.6551724137931
R&D to revenue (%): 10.671506352087114
SG&A to revenue (%): 39.96370235934664
Free cash flow (dilution-adjusted): -52000
Buyback yield (%): 0
Retained earnings: 11935000
Inventory turnover: 0.6745562130177515
Receivables turnover: 1.8665311653116532
Capitalized R&D asset: 523410
ROCI (R&D-adjusted, %): 0.24553885239486203
Rosenberg metric: -0.29957805907172996
FCF margin (%): -1.8874773139745917
Revenue growth (%): 0.2547307132459971
Rule of 40 score: -1.6327466007285947
Financial ratios for ELVN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9
Shares outstanding: 71438280
Market cap (USD): 642944520
Buyback yield (%): 0.035150777861828575
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELVN — annual report dated 2022-12-31
Total revenue: 0
Operating income: -38791000
Net income: -37662000
Capital expenditures: 612000
Operating cash flow: -32077000
Depreciation & amortization: 215000
Net tangible assets: -76825000
Owner earnings: -38059000
Buffett classification: The Gruesome
Stock price: 16.36
Shares outstanding: 71438280
Book value: -76825000
Market cap (USD): 1168730260.8
Debt to equity: -0.004204360559713635
Current ratio: 8.003396809058158
Quick ratio: 8.003396809058158
Free cash flow (dilution-adjusted): -35880000
Buyback yield (%): 0
Retained earnings: -82864000
Capitalized R&D asset: 31022000
ROCI (R&D-adjusted, %): -17.31242929751605
Rule of 40 score: 0
Financial ratios for ELVN — annual report dated 2023-12-31
Total revenue: 0
Operating income: -83529000
Net income: -71584000
Capital expenditures: 149000
Operating cash flow: -61269000
Depreciation & amortization: 297000
Net tangible assets: 245906000
Owner earnings: -71436000
Return on net tangible assets (%): -29.050124844452757
Buffett classification: The Gruesome
Stock price: 13.84
Shares outstanding: 71438280
Book value: 245906000
P/B ratio: 4.020665600676682
Market cap (USD): 988705795.2
Debt to equity: 0.001362309175050629
Current ratio: 10.27848150150614
Quick ratio: 10.27848150150614
Free cash flow (dilution-adjusted): -74332000
Buyback yield (%): 0
Retained earnings: -154448000
Capitalized R&D asset: 85358740
ROCI (R&D-adjusted, %): -15.338202531798895
Rule of 40 score: 0
Financial ratios for ELVN — quarterly report dated 2024-09-30
Capital expenditures: 22000
Buffett classification: The Gruesome
Stock price: 25.54
Shares outstanding: 71438280
Market cap (USD): 1824533671.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELVN — annual report dated 2024-12-31
Total revenue: 0
Operating income: -104554000
Net income: -89024000
Capital expenditures: 44000
Operating cash flow: -73192000
Depreciation & amortization: 317000
Net tangible assets: 309845000
Owner earnings: -88751000
Return on net tangible assets (%): -28.6436766770482
Buffett classification: The Gruesome
Stock price: 22.5
Shares outstanding: 71438280
Book value: 309845000
P/B ratio: 5.187630266746277
Market cap (USD): 1607361300
Debt to equity: 0
Current ratio: 19.989129751806473
Quick ratio: 19.989129751806473
Free cash flow (dilution-adjusted): -93410000
Buyback yield (%): 0
Retained earnings: -243472000
Capitalized R&D asset: 134279840
ROCI (R&D-adjusted, %): -18.59101898766422
Rule of 40 score: 0
Financial ratios for ELVN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.5
Shares outstanding: 71438280
Market cap (USD): 1607361300
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELVN — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -31693000
Net income: -28544000
Capital expenditures: 20000
Operating cash flow: -24127000
Depreciation & amortization: 74000
Net tangible assets: 288296000
Owner earnings: -28490000
Return on net tangible assets (%): -9.882204401032272
Buffett classification: The Gruesome
Stock price: 19.68
Shares outstanding: 71438280
Book value: 288296000
P/B ratio: 4.876603735050087
Market cap (USD): 1405905350.4
Debt to equity: 0.0012660598828981326
Current ratio: 21.06484397366161
Quick ratio: 21.06484397366161
Free cash flow (dilution-adjusted): -30946000
Buyback yield (%): 0
Retained earnings: -272016000
Capitalized R&D asset: 24895000
ROCI (R&D-adjusted, %): -4.815524854887775
Rule of 40 score: 0
Financial ratios for ELVN — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -28584000
Net income: -25335000
Capital expenditures: 139000
Operating cash flow: -17057000
Depreciation & amortization: 81000
Net tangible assets: 488472000
Owner earnings: -25393000
Return on net tangible assets (%): -5.1984555921322
Buffett classification: The Gruesome
Stock price: 20.06
Shares outstanding: 71438280
Book value: 488472000
P/B ratio: 2.933744199872254
Market cap (USD): 1433051896.8
Debt to equity: 0.001187376144384939
Current ratio: 32.583130629149956
Quick ratio: 32.583130629149956
Free cash flow (dilution-adjusted): -24920000
Buyback yield (%): 0
Retained earnings: -297351000
Capitalized R&D asset: 38170650
ROCI (R&D-adjusted, %): -4.281131900525514
Rule of 40 score: 0
Financial ratios for ELVN — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -25096000
Net income: -20148000
Capital expenditures: 1000
Operating cash flow: -13279000
Depreciation & amortization: 62000
Net tangible assets: 476122000
Owner earnings: -20087000
Return on net tangible assets (%): -4.218876674465788
Buffett classification: The Gruesome
Stock price: 20.47
Shares outstanding: 71438280
Book value: 476122000
P/B ratio: 3.0713590037847442
Market cap (USD): 1462341591.6
Debt to equity: 0.0008128168830677852
Current ratio: 32.94764505119454
Quick ratio: 32.94764505119454
Free cash flow (dilution-adjusted): -20463000
Buyback yield (%): 0
Retained earnings: -317499000
Capitalized R&D asset: 40839320
ROCI (R&D-adjusted, %): -5.494094042304059
Rule of 40 score: 0
Financial ratios for ELVN — annual report dated 2025-12-31
Total revenue: 0
Operating income: -119658000
Net income: -103694000
Capital expenditures: 55000
Operating cash flow: -70301000
Depreciation & amortization: 263000
Net tangible assets: 459600000
Owner earnings: -103486000
Return on net tangible assets (%): -22.516536118363796
Buffett classification: The Gruesome
Stock price: 15.4
Shares outstanding: 71438280
Book value: 459600000
P/B ratio: 2.393710861618799
Market cap (USD): 1100149512
Debt to equity: 0.0008681462140992167
Current ratio: 28.662361178174795
Quick ratio: 28.662361178174795
Free cash flow (dilution-adjusted): -104478000
Buyback yield (%): 0
Retained earnings: -347166000
Capitalized R&D asset: 161286680
ROCI (R&D-adjusted, %): -17.856935396541818
Rule of 40 score: 0
Financial ratios for ELVN — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -34285000
Net income: -29667000
Capital expenditures: 213000
Operating cash flow: -15838000
Depreciation & amortization: 46000
Net tangible assets: 459600000
Owner earnings: -29834000
Return on net tangible assets (%): -6.491296779808529
Buffett classification: The Gruesome
Stock price: 15.4
Shares outstanding: 71438280
Book value: 459600000
P/B ratio: 2.393710861618799
Market cap (USD): 1100149512
Debt to equity: 0.0008681462140992167
Current ratio: 28.662361178174795
Quick ratio: 28.662361178174795
Free cash flow (dilution-adjusted): -28149000
Buyback yield (%): 0
Retained earnings: -347166000
Capitalized R&D asset: 40547780
ROCI (R&D-adjusted, %): -6.6700952533135975
Rule of 40 score: 0
Financial ratios for FDY.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.5984251968503937
Shares outstanding: 292271075
Market cap (USD): 174902375.5905512
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FDY.TO — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -40903.67647058823
Operating income: -15834255.147058822
Net income: -15685310.294117646
Capital expenditures: 879183.8235294117
Operating cash flow: -10640938.970588235
Depreciation & amortization: 40903.67647058823
Net tangible assets: 9868231.617647057
Owner earnings: -16523590.441176469
Return on net tangible assets (%): -167.4422640387548
Buffett classification: The Gruesome
Stock price: 0.39705882352941174
Shares outstanding: 292271075
Book value: 9868231.61764706
P/B ratio: 11.759838407486292
Market cap (USD): 116048809.19117646
Debt to equity: 0
Current ratio: 3.1022736731895075
Quick ratio: 3.1022736731895075
Free cash flow (dilution-adjusted): -14863756.617647057
Buyback yield (%): 0
Retained earnings: -41882504.4117647
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -160.4568656327736
Rule of 40 score: 0
Financial ratios for FDY.TO — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -102136.36363636363
Operating income: -16359718.181818182
Net income: -15530275.757575756
Capital expenditures: 11109918.181818182
Operating cash flow: -14384239.393939393
Depreciation & amortization: 102136.36363636363
Net tangible assets: 25837415.909090906
Owner earnings: -26538057.575757574
Return on net tangible assets (%): -102.71173274112195
Buffett classification: The Gruesome
Stock price: 0.47727272727272724
Shares outstanding: 292271075
Book value: 25837415.909090906
P/B ratio: 5.398876325673928
Market cap (USD): 139493013.0681818
Debt to equity: 0
Current ratio: 6.144476831971731
Quick ratio: 6.144476831971731
Free cash flow (dilution-adjusted): -27133100
Buyback yield (%): 0.0429509944948652
Retained earnings: -58681946.96969697
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -63.31793488706433
Rule of 40 score: 0
Financial ratios for FDY.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.6148148148148147
Shares outstanding: 292271075
Market cap (USD): 179692586.85185182
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FDY.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.5174825174825175
Shares outstanding: 292271075
Market cap (USD): 151245171.6783217
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FDY.TO — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -147134.26573426573
Operating income: -16573233.566433568
Net income: -15768327.972027972
Capital expenditures: 350476.92307692306
Operating cash flow: -13680105.594405595
Depreciation & amortization: 147134.26573426573
Net tangible assets: 25359178.32167832
Owner earnings: -15971670.62937063
Return on net tangible assets (%): -62.98181442147607
Buffett classification: The Gruesome
Stock price: 0.5174825174825175
Shares outstanding: 292271075
Book value: 25359178.321678326
P/B ratio: 5.964119568851707
Market cap (USD): 151245171.6783217
Debt to equity: 0
Current ratio: 4.042999749684789
Quick ratio: 4.042999749684789
Free cash flow (dilution-adjusted): -14806159.440559441
Buyback yield (%): 0
Retained earnings: -69936279.02097902
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -65.35398488154452
Rule of 40 score: 0
Financial ratios for FDY.TO — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -44964.33566433567
Operating income: -5485943.356643357
Net income: -5468832.867132868
Capital expenditures: 155665.03496503498
Operating cash flow: -6471056.643356644
Depreciation & amortization: 44964.33566433567
Net tangible assets: 20164181.11888112
Owner earnings: -5579533.566433567
Return on net tangible assets (%): -27.670518993747095
Buffett classification: The Gruesome
Stock price: 0.5734265734265734
Shares outstanding: 292271075
Book value: 20164181.118881118
P/B ratio: 8.311569910072832
Market cap (USD): 167596001.04895106
Debt to equity: 0
Current ratio: 3.212469794132409
Quick ratio: 3.212469794132409
Free cash flow (dilution-adjusted): -6895341.258741259
Buyback yield (%): 0
Retained earnings: -75405111.88811189
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.206378103331403
Rule of 40 score: 0
Financial ratios for FDY.TO — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -48573.722627737225
Operating income: -4058732.1167883207
Net income: -3952102.189781022
Capital expenditures: 26938.686131386858
Operating cash flow: -3772859.1240875907
Depreciation & amortization: 48573.722627737225
Net tangible assets: 16787288.321167883
Owner earnings: -3930467.1532846717
Return on net tangible assets (%): -23.41335347370284
Buffett classification: The Gruesome
Stock price: 0.6642335766423357
Shares outstanding: 292271075
Book value: 16787288.321167883
P/B ratio: 11.564480086492278
Market cap (USD): 194136261.49635035
Debt to equity: 0
Current ratio: 1.3359323773762835
Quick ratio: 1.3359323773762835
Free cash flow (dilution-adjusted): -4137518.9781021895
Buyback yield (%): 0
Retained earnings: -82659627.73722628
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -24.17741352348416
Rule of 40 score: 0
Financial ratios for FDY.TO — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -54567.62589928058
Operating income: -4396426.618705036
Net income: -3926294.244604317
Capital expenditures: 208635.25179856116
Operating cash flow: -2586761.8705035974
Depreciation & amortization: 54567.62589928058
Net tangible assets: 47240164.02877698
Owner earnings: -4080361.870503598
Return on net tangible assets (%): -8.63748455237791
Buffett classification: The Gruesome
Stock price: 1.2949640287769786
Shares outstanding: 292271075
Book value: 47240164.02877699
P/B ratio: 8.011837735076913
Market cap (USD): 378480528.7769785
Debt to equity: 0
Current ratio: 13.276089612030376
Quick ratio: 13.276089612030376
Free cash flow (dilution-adjusted): -3131114.3884892086
Buyback yield (%): 0
Retained earnings: -85396574.8201439
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.30654393161483
Rule of 40 score: 0
Financial ratios for FDY.TO — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -66903.64963503649
Operating income: -6710886.131386861
Net income: -6698027.737226277
Capital expenditures: 147042.33576642335
Operating cash flow: -6710023.357664233
Depreciation & amortization: 66903.64963503649
Net tangible assets: 42356815.32846715
Owner earnings: -6778166.423357664
Return on net tangible assets (%): -16.00254025425324
Buffett classification: The Gruesome
Stock price: 1.9927007299270072
Shares outstanding: 292271075
Book value: 42356815.32846715
P/B ratio: 13.750060762892767
Market cap (USD): 582408784.4890511
Debt to equity: 0
Current ratio: 11.986823953403261
Quick ratio: 11.986823953403261
Free cash flow (dilution-adjusted): -7196000.729927007
Buyback yield (%): 0
Retained earnings: -93341267.88321167
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.77784815390071
Rule of 40 score: 0
Financial ratios for FDY.TO — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -217775.1824817518
Operating income: -20956429.9270073
Net income: -20342086.13138686
Capital expenditures: 548144.5255474452
Operating cash flow: -19861867.883211676
Depreciation & amortization: 217775.1824817518
Net tangible assets: 42356815.32846715
Owner earnings: -20672455.474452555
Return on net tangible assets (%): -48.80549992756188
Buffett classification: The Gruesome
Stock price: 1.9927007299270072
Shares outstanding: 292271075
Book value: 42356815.32846715
P/B ratio: 13.750060762892767
Market cap (USD): 582408784.4890511
Debt to equity: 0
Current ratio: 11.986823953403261
Quick ratio: 11.986823953403261
Free cash flow (dilution-adjusted): -21707670.802919704
Buyback yield (%): 0
Retained earnings: -93341267.88321167
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -49.27029944521657
Rule of 40 score: 0
Financial ratios for GBFH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.8
Shares outstanding: 14470352
Market cap (USD): 315453673.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GBFH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 43
Shares outstanding: 14470352
Market cap (USD): 622225136
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GBFH — annual report dated 2024-12-31
Total revenue: 60707000
Net income: 18636000
Capital expenditures: 194000
Operating cash flow: 26482000
Depreciation & amortization: 5918000
Net tangible assets: 131724000
Owner earnings: 24360000
Return on net tangible assets (%): 18.493213081898517
Buffett classification: The Gruesome
Stock price: 43
P/E ratio: 33.388341704228374
Shares outstanding: 14470352
Book value: 140700000
P/B ratio: 4.422353489694385
Market cap (USD): 622225136
Debt to equity: 0.21980810234541578
Effective tax rate (%): 22.05771643663739
COGS to revenue (%): 0
SG&A to revenue (%): 38.48814798952345
Free cash flow (dilution-adjusted): 24354000
Buyback yield (%): 0
Retained earnings: 64437000
Capitalized R&D asset: 0
FCF margin (%): 40.11728466239478
Revenue growth (%): 32.623323283960325
Rule of 40 score: 72.74060794635511
Financial ratios for GBFH — quarterly report dated 2025-03-31
Total revenue: 16973000
Net income: 4470000
Capital expenditures: 32000
Operating cash flow: -5682000
Depreciation & amortization: 1528000
Net tangible assets: 146616000
Owner earnings: 5966000
Return on net tangible assets (%): 4.0691329732089265
Buffett classification: The Gruesome
Stock price: 37.4
P/E ratio: 30.267962237136462
Shares outstanding: 14470352
Book value: 146616000
P/B ratio: 3.6912149069678617
Market cap (USD): 541191164.8
Debt to equity: 0.22102635455884762
Effective tax rate (%): 21.364985163204746
COGS to revenue (%): 0
SG&A to revenue (%): 40.570317563188595
Free cash flow (dilution-adjusted): -6288000
Buyback yield (%): 0
Retained earnings: 68907000
Capitalized R&D asset: 0
FCF margin (%): -37.04707476580451
Rule of 40 score: -37.04707476580451
Financial ratios for GBFH — quarterly report dated 2025-06-30
Total revenue: 17442000
Net income: 4755000
Capital expenditures: 19000
Operating cash flow: 859000
Depreciation & amortization: 1664000
Net tangible assets: 151749000
Owner earnings: 6400000
Return on net tangible assets (%): 4.2174907248153195
Buffett classification: The Gruesome
Stock price: 35.41
P/E ratio: 55.544191254200534
Shares outstanding: 14470352
Book value: 151749000
P/B ratio: 3.376596645249721
Market cap (USD): 512395164.31999993
Debt to equity: 0.2125022240673744
Effective tax rate (%): 23.647358370464673
COGS to revenue (%): 0
SG&A to revenue (%): 38.61369109047128
Free cash flow (dilution-adjusted): 266000
Buyback yield (%): 0
Retained earnings: 73662000
Capitalized R&D asset: 0
FCF margin (%): 1.5250544662309369
Revenue growth (%): 2.7632121604901903
Rule of 40 score: 4.288266626721127
Financial ratios for GBFH — quarterly report dated 2025-09-30
Total revenue: 19599000
Net income: 4308000
Capital expenditures: 144000
Operating cash flow: -12204000
Depreciation & amortization: 1789000
Net tangible assets: 158193000
Owner earnings: 5953000
Return on net tangible assets (%): 3.7631247906038827
Buffett classification: The Gruesome
Stock price: 39.27
P/E ratio: 41.99000391930836
Shares outstanding: 14470352
Book value: 158193000
P/B ratio: 3.592135701579716
Market cap (USD): 568250723.0400001
Debt to equity: 0.20282819088075957
Effective tax rate (%): 22.734527398474906
COGS to revenue (%): 0
SG&A to revenue (%): 40.12449614776264
Free cash flow (dilution-adjusted): -12871000
Buyback yield (%): 0
Retained earnings: 77970000
Capitalized R&D asset: 0
FCF margin (%): -65.6717179447931
Revenue growth (%): 12.36670106639147
Rule of 40 score: -53.30501687840163
Financial ratios for GBFH — quarterly report dated 2025-12-31
Total revenue: 19950000
Net income: 7396000
Capital expenditures: 301000
Operating cash flow: 26666000
Depreciation & amortization: 1765000
Net tangible assets: 154615000
Owner earnings: 8860000
Return on net tangible assets (%): 5.7303625133395855
Buffett classification: The Gruesome
Stock price: 33.89
P/E ratio: 23.431613038367818
Shares outstanding: 14470352
Book value: 165755000
P/B ratio: 2.958584834725951
Market cap (USD): 490400229.28000003
Debt to equity: 0.19481161955898765
Effective tax rate (%): 21.470183243300497
COGS to revenue (%): 0
SG&A to revenue (%): 36.43107769423558
Free cash flow (dilution-adjusted): 25976000
Buyback yield (%): 0
Retained earnings: 85366000
Capitalized R&D asset: 0
FCF margin (%): 130.20551378446115
Revenue growth (%): 1.790907699372417
Rule of 40 score: 131.99642148383356
Financial ratios for GBFH — annual report dated 2025-12-31
Total revenue: 73963000
Net income: 20929000
Capital expenditures: 496000
Operating cash flow: 9639000
Depreciation & amortization: 6746000
Net tangible assets: 154615000
Owner earnings: 27179000
Return on net tangible assets (%): 17.578501439058307
Buffett classification: The Gruesome
Stock price: 33.89
P/E ratio: 23.431613038367818
Shares outstanding: 14470352
Book value: 165755000
P/B ratio: 2.958584834725951
Market cap (USD): 490400229.28000003
Debt to equity: 0.19481161955898765
Effective tax rate (%): 22.2160705717344
COGS to revenue (%): 0
SG&A to revenue (%): 38.87484282681882
Free cash flow (dilution-adjusted): 7083000
Buyback yield (%): 0
Retained earnings: 85366000
Capitalized R&D asset: 0
FCF margin (%): 9.576409826534888
Revenue growth (%): 21.836032088556507
Rule of 40 score: 31.412441915091396
Financial ratios for GMED — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 72.2
Shares outstanding: 113314529
Market cap (USD): 8181308993.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GMED — annual report dated 2022-12-31
Total revenue: 1022843000
Gross profit: 759118000
Operating income: 236251000
Net income: 190169000
Capital expenditures: 74047000
Operating cash flow: 178468000
Depreciation & amortization: 68252000
Net tangible assets: 1585328000
Owner earnings: 184374000
Return on net tangible assets (%): 11.630022304532565
Capex to operating income (%): 31.342512835924502
Buffett classification: The Good
Stock price: 74.27
P/E ratio: 44.2546896120293
Shares outstanding: 113314529
Book value: 1846373000
P/B ratio: 4.558055208145916
Market cap (USD): 8415870068.83
Debt to equity: 0.00325557186982262
Current ratio: 6.176628727921409
Quick ratio: 4.298654556418181
Effective tax rate (%): 21.747270789526745
COGS to revenue (%): 25.783526895134447
R&D to revenue (%): 7.138436690674912
SG&A to revenue (%): 42.2466595557676
Free cash flow (dilution-adjusted): 71611000
Buyback yield (%): 1.7169110123879072
Retained earnings: 1239951000
Inventory turnover: 0.8820794632434837
Receivables turnover: 4.706881476981979
Capitalized R&D asset: 73015000
ROCI (R&D-adjusted, %): 14.318426496249211
FCF margin (%): 7.001172222912021
Rule of 40 score: 7.001172222912021
Financial ratios for GMED — annual report dated 2023-12-31
Total revenue: 1568476000
Gross profit: 1020302000
Operating income: 201416000
Net income: 122873000
Capital expenditures: 78274000
Operating cash flow: 243499000
Depreciation & amortization: 145526000
Net tangible assets: 1638816000
Owner earnings: 190125000
Return on net tangible assets (%): 11.601363423349541
Capex to operating income (%): 38.86185804504111
Buffett classification: The Good
Stock price: 53.29
P/E ratio: 49.14449269090849
Shares outstanding: 113314529
Book value: 3997959000
P/B ratio: 1.5104034959863268
Market cap (USD): 6038531250.41
Debt to equity: 0.13016741792499623
Current ratio: 4.881836741455905
Quick ratio: 2.7201405898350184
Effective tax rate (%): 25.708464082518606
COGS to revenue (%): 34.949466871026395
R&D to revenue (%): 7.906400863003323
SG&A to revenue (%): 41.049018282715195
Free cash flow (dilution-adjusted): 112483000
Buyback yield (%): 3.7353785323986686
Retained earnings: 1137266000
Inventory turnover: 0.6463287094625266
Receivables turnover: 3.106692812011013
Capitalized R&D asset: 172930050
ROCI (R&D-adjusted, %): 5.3373499913765405
Rosenberg metric: 3.5771279873998494
FCF margin (%): 7.171483656747059
Revenue growth (%): 53.344745967856255
Rule of 40 score: 60.51622962460331
Financial ratios for GMED — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 36871000
Buffett classification: The Gruesome
Stock price: 71.54
Shares outstanding: 113314529
Market cap (USD): 8106521404.660001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GMED — annual report dated 2024-12-31
Total revenue: 2519355000
Gross profit: 1483876000
Operating income: 219387000
Net income: 102984000
Capital expenditures: 115429000
Operating cash flow: 520638000
Depreciation & amortization: 253389000
Net tangible assets: 1949829000
Owner earnings: 240944000
Return on net tangible assets (%): 12.357186194276522
Capex to operating income (%): 52.61432992839138
Buffett classification: The Good
Stock price: 82.71
P/E ratio: 91.00680390730598
Shares outstanding: 113314529
Book value: 4177333000
P/B ratio: 2.243595301976165
Market cap (USD): 9372244693.59
Debt to equity: 0.12859592472038978
Current ratio: 2.5437865764394276
Quick ratio: 1.7735762863749003
Effective tax rate (%): 14.693262205728866
COGS to revenue (%): 41.10095639558538
R&D to revenue (%): 6.499838252251072
SG&A to revenue (%): 38.95290659712506
Free cash flow (dilution-adjusted): 351018000
Buyback yield (%): 0.9153303483281083
Retained earnings: 1152813000
Inventory turnover: 1.570732957846467
Receivables turnover: 4.356258537513185
Capitalized R&D asset: 270935650
ROCI (R&D-adjusted, %): 5.633043498129983
Rosenberg metric: 3.7381985323764213
FCF margin (%): 13.932851860892967
Revenue growth (%): 60.62438953480959
Rule of 40 score: 74.55724139570256
Financial ratios for GMED — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 82.71
Shares outstanding: 113314529
Market cap (USD): 9372244693.59
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GMED — quarterly report dated 2025-03-31
Total revenue: 598121000
Gross profit: 402724000
Operating income: 98061000
Net income: 75462000
Capital expenditures: 36103000
Operating cash flow: 177300000
Depreciation & amortization: 65653000
Net tangible assets: 1883416000
Owner earnings: 105012000
Return on net tangible assets (%): 5.575613672178637
Capex to operating income (%): 36.81687928942189
Buffett classification: The Good
Stock price: 73.2
P/E ratio: 27.47947153136678
Shares outstanding: 113314529
Book value: 4088068000
P/B ratio: 2.028983745573704
Market cap (USD): 8294623522.8
Debt to equity: 0.02258108231076391
Current ratio: 4.445306874689694
Quick ratio: 2.720323056087715
Effective tax rate (%): 27.208010186364163
COGS to revenue (%): 32.668473435977
R&D to revenue (%): 5.527644072018872
SG&A to revenue (%): 40.593625704497924
Free cash flow (dilution-adjusted): 127991000
Buyback yield (%): 2.296077687872081
Retained earnings: 1036173000
Inventory turnover: 0.29444863871923427
Receivables turnover: 1.1115135454569107
Capitalized R&D asset: 33062000
ROCI (R&D-adjusted, %): 2.7549509206961913
FCF margin (%): 21.39884739041097
Rule of 40 score: 21.39884739041097
Financial ratios for GMED — quarterly report dated 2025-06-30
Total revenue: 745342000
Gross profit: 496577000
Operating income: 122812000
Net income: 202846000
Capital expenditures: 46562000
Operating cash flow: 77865000
Depreciation & amortization: 71052000
Net tangible assets: 2064328000
Owner earnings: 227336000
Return on net tangible assets (%): 11.012591022356913
Capex to operating income (%): 37.913233234537344
Buffett classification: The Good
Stock price: 59.02
P/E ratio: 24.03029557748969
Shares outstanding: 113314529
Book value: 4295683000
P/B ratio: 1.5568708169527408
Market cap (USD): 6687823501.58
Debt to equity: 0.028192024411484738
Current ratio: 4.073578170035605
Quick ratio: 2.2553618861028957
Effective tax rate (%): -7.797611772145845
COGS to revenue (%): 33.37595358909064
R&D to revenue (%): 5.360492230412348
SG&A to revenue (%): 40.73593061976918
Free cash flow (dilution-adjusted): 12686000
Buyback yield (%): 0.3738136928119252
Retained earnings: 1213657000
Inventory turnover: 0.32217978555452376
Receivables turnover: 1.1290956382371165
Capitalized R&D asset: 62105540
ROCI (R&D-adjusted, %): 3.0102514733616044
Rosenberg metric: 2.8386969935273125
FCF margin (%): 1.7020374539473155
Revenue growth (%): 24.613915913335262
Rule of 40 score: 26.315953367282578
Financial ratios for GMED — quarterly report dated 2025-09-30
Total revenue: 769048000
Gross profit: 516515000
Operating income: 135008000
Net income: 118966000
Capital expenditures: 35817000
Operating cash flow: 249695000
Depreciation & amortization: 71126000
Net tangible assets: 2190632000
Owner earnings: 154275000
Return on net tangible assets (%): 7.042488195187508
Capex to operating income (%): 26.52953899028206
Buffett classification: The Good
Stock price: 57.27
P/E ratio: 16.335131611507425
Shares outstanding: 113314529
Book value: 4398825000
P/B ratio: 1.4752855764505295
Market cap (USD): 6489523075.83
Debt to equity: 0.027130654208794396
Current ratio: 4.129902265869456
Quick ratio: 2.4740920855527753
Effective tax rate (%): 17.381279775546204
COGS to revenue (%): 32.83709209308132
R&D to revenue (%): 4.949886092935682
SG&A to revenue (%): 40.77729868616783
Free cash flow (dilution-adjusted): 197674000
Buyback yield (%): 0.61637811488765
Retained earnings: 1292485000
Inventory turnover: 0.3273111628980037
Receivables turnover: 1.1176025216422063
Capitalized R&D asset: 75746640
ROCI (R&D-adjusted, %): 2.8912845936461453
Rosenberg metric: 0.49902387745907795
FCF margin (%): 25.703727205584048
Revenue growth (%): 3.180553356714099
Rule of 40 score: 28.884280562298148